Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 22 for “"Pharmacy Administration"”.
-
Reducing Medication Errors by Systematically Monitoring High-Risk Medications
<p>Reducing Medication Errors by Systematically Monitoring High-Risk Medications</p> <p>The project is performed in a pulmonary outpatient clinic, with a patient population of mostly men 60-80 years old with severe abnormal lung findings and often with multiple comorbidities. The clinic is staffed …
-
Evaluation of Clinical Pharmacy Impact on Multiple Internal Medicine Teams Utilizing Alternative Rounding Strategies
… Medical Center (MEDVAMC), the inpatient clinical pharmacy section has a total of five internal medicine (IM) clinical pharmacy specialists (CPSs) allotted for ten IM teams. Challenges were identified in meeting the needs of both assigned teams (e.g. rounding and medication reconciliation). Various …
-
An Economic and Regulatory Analysis of Gene Therapy Products Authorized by the US Food and Drug Administration and the European Medicines Agency
… of gene therapy products by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), evaluated the post-marketing safety signals reported to the FDA Adverse Event Reporting System (FAERS), and assessed the cost-effectiveness analysis of three gene therapies axicabtagene …
-
The Effects Orthostatic Hypotension has on Falls: A study done in San Francisco with the Patient Population of the Veterans Affairs Hospital
… falls by 50%. The project started working with pharmacy and IT to change the charting process and identify patients that are on medications that could cause OH. These changes will not be in effect due to the projects length of 3.5 months, but the CNL preceptor will continue the project with the …
-
Pharmacovigilance in Post-Marketing: Risk Assessment and Reporting Standards
… is so prominent that the Food and Drug Administration (FDA) required Letairis be placed on the risk evaluation and mitigation strategy program (REMS) to continually assess the risks and benefits of the product during post-marketing. In order to prevent and reduce harm in patients, …
-
An Analysis of Trends of Generic Drugs and Biologic Prices in the U.S.
<p><strong>Introduction:</strong> Drug prices are a significant problem for the US healthcare system. Generic and biosimilar market competition reduces drug and biologic prices, results in substantial savings, and improves patient access and outcomes. As the costs of healthcare and prescription …
-
Orphan Drugs: Designations, Approvals, and Prices in the US
<p><strong>Introduction.</strong> Rare disease drug approvals have accelerated significantly in recent years. Even with these advances, patients continue to face challenges in receiving treatment, with most rare diseases lacking any approved treatments. Moreover, even when a treatment is available, …
-
The Potential for Screening for Interpersonal Violence in Community Pharmacies: an Exploratory Study
… Expansion of screening efforts to the community pharmacy setting provides an opportunity to have a substantial impact on the health, well-being of pharmacy patients. This investigation is the first to examine IPV screening related to the pharmacy environment. An existing measure of physicians' …
-
An Economic and Regulatory Analysis of Breast Cancer Drugs Approved by the US Food and Drug Administration
<p><strong>Introduction</strong></p> <p>Breast cancer is the most common cancer among women and the leading cause of cancer death among women worldwide. The pharmacological options for breast cancer include chemotherapy, hormone therapy, targeted therapy, and immunotherapy, which are used for the …
-
Community Pharmacists and Substance Use Disorders: Attitudes, Knowledge and Practices
… relationships and improve their delivery of pharmacy services</p> <p><strong>Objective: </strong>To assess knowledge, practices (with an emphasis upon screening), stigma and general attitudes of community pharmacists towards SUD and evaluate the relationship between these factors.</p> …
-
Approvals, Utilization, and Cost of Biologics for the Treatment of Rheumatoid Arthritis
<p><strong>Introduction:</strong> RA treatment has been revolutionized by the development and approval of biologic disease-modifying antirheumatic drugs (bDMARDs). However, the approval status, utilization, and high cost of bDMARDs pose challenges in RA management.</p> …
-
Approvals and Prices of Systemic Antibiotics in Saudi Arabia and the United States
… regulatory data from the US Food and Drug Administration (FDA) and the Saudi Food and Drug Authority (SFDA), the National Average Drug Acquisition Cost (NADAC) and the average sales price (ASP) data from the Center for Medicare and Medicaid Services (CMS), and Saudi prices from the SFDA …
-
Evaluating Consumer Preferences for Medicare Part D Using Conjoint Analysis
… score of 12.1%), deductible (11.6%) and pharmacy access (10.1%). Seniors with higher incomes, those taking more than seven medications, and those with monthly medication costs above $80 were less sensitive to premium increases than other groups. As a group, the seniors were willing to pay …
-
Patient Satisfaction with Substance Use Disorder Rehabilitation Services
<p><strong>Background</strong>: Patient satisfaction is considered as an important indicator in the evaluation of healthcare quality across an array of treatments and services. It is deemed vital especially in the field of substance use disorder (SUD) research due to an increased emphasis on …
-
Authorizations, Prices, and Labeling Differences of Therapeutic Biologics Marketed in the United States and Saudi Arabia
… Food and Drug Authority (SFDA) and Food and Drug Administration (FDA) as of December 31, 2021. The study also compared the US and SA biologics prices between 2016 and 2019. This study also assessed the differences in indications and safety information on the therapeutic biologics labels authorized …
-
An Exploration of Ambulatory Visits and Medications Prescribed for Patients Diagnosed with Lupus Erythematosus in the United States
<p>This dissertation sought to understand the management and treatment of patients diagnosed with lupus erythematosus. To accomplish the objectives of this research, three studies were conducted. First, a systematic literature review was done to assess the current landscape of available clinical …
-
Cost-Effectiveness Analysis of Tisagenlecleucel, Blinatumomab, and Clofarabine for Treatment of B-cell Precursor Acute Lymphoblastic Leukemia
<p>Acute lymphoblastic leukemia (ALL) is a common type of adolescent and young adult leukemia in the United States (U.S.). Patients who are refractory or relapsed after receiving two or more lines of systemic therapy have the option of taking tisagenlecleucel. Due to the high cost of this …
-
The Association Between Medication Adherence in Mental Illness and Substance Use Disorder Relapse in Patients with Dual Diagnosis
<p>Objectives: The aims of the study were to (1) identify personal, social, and clinical history for patients with substance use disorder (SUD) and mental illness, (2) measure agreeance between patient self-report versus facility record history for mental illness, substance abuse, and psychotropic …
-
Awareness And Utilization Of The Ohio Automated Rx Reporting System By Physician Assistants
<p>Chronic pain has become a public health epidemic. As pain complaints increase, so does the potential for drug abuse/misuse. Prescription drug monitoring programs (PDMPs) are active in 49 of the 50 states to assist providers in recognizing drug abuse/misuse. There is no clear standardization of …
-
Burden of Illness and Pharmacoeconomic Evaluation of Lumacaftor/Ivacaftor in Cystic Fibrosis
… acquisition costs from 2015 Redbook), drug administration/monitoring costs from package inserts, Centers for Medicare and Medicaid 2016 Physician Fee Schedule and published literature, percentage predicted forced expiratory volume (FEV<sub>1</sub>% predicted)and pulmonary exacerbation values …
Page 1 of 2